187 related articles for article (PubMed ID: 22966165)
1. Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.
Tel J; Smits EL; Anguille S; Joshi RN; Figdor CG; de Vries IJ
Blood; 2012 Nov; 120(19):3936-44. PubMed ID: 22966165
[TBL] [Abstract][Full Text] [Related]
2. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
5. Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.
Cordeau M; Belounis A; Lelaidier M; Cordeiro P; Sartelet H; Herblot S; Duval M
PLoS One; 2016; 11(10):e0164401. PubMed ID: 27716850
[TBL] [Abstract][Full Text] [Related]
6. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
7. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
8. Tumoricidal activity of human dendritic cells.
Tel J; Anguille S; Waterborg CE; Smits EL; Figdor CG; de Vries IJ
Trends Immunol; 2014 Jan; 35(1):38-46. PubMed ID: 24262387
[TBL] [Abstract][Full Text] [Related]
9. Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells.
Colisson R; Barblu L; Gras C; Raynaud F; Hadj-Slimane R; Pique C; Hermine O; Lepelletier Y; Herbeuval JP
Blood; 2010 Mar; 115(11):2177-85. PubMed ID: 20007807
[TBL] [Abstract][Full Text] [Related]
10. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion.
Tel J; Sittig SP; Blom RA; Cruz LJ; Schreibelt G; Figdor CG; de Vries IJ
J Immunol; 2013 Nov; 191(10):5005-12. PubMed ID: 24127556
[TBL] [Abstract][Full Text] [Related]
11. TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
Wu J; Li S; Yang Y; Zhu S; Zhang M; Qiao Y; Liu YJ; Chen J
Oncotarget; 2017 Feb; 8(7):11708-11718. PubMed ID: 28052019
[TBL] [Abstract][Full Text] [Related]
12. IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.
Matta BM; Raimondi G; Rosborough BR; Sumpter TL; Thomson AW
J Immunol; 2012 Jun; 188(11):5227-37. PubMed ID: 22508931
[TBL] [Abstract][Full Text] [Related]
13. IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation.
Karrich JJ; Jachimowski LC; Nagasawa M; Kamp A; Balzarolo M; Wolkers MC; Uittenbogaart CH; Marieke van Ham S; Blom B
Blood; 2013 Apr; 121(16):3103-11. PubMed ID: 23407551
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
[TBL] [Abstract][Full Text] [Related]
15. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
[TBL] [Abstract][Full Text] [Related]
18. Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
Ruben JM; García-Romo GS; Breman E; van der Kooij S; Redeker A; Arens R; van Kooten C
Kidney Int; 2018 Feb; 93(2):355-364. PubMed ID: 29061332
[TBL] [Abstract][Full Text] [Related]
19. Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells.
Kawamura K; Kadowaki N; Kitawaki T; Uchiyama T
Blood; 2006 Feb; 107(3):1031-8. PubMed ID: 16219801
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc
Wagner F; Hölig U; Wilczkowski F; Plesca I; Sommer U; Wehner R; Kießler M; Jarosch A; Flecke K; Arsova M; Tunger A; Bogner A; Reißfelder C; Weitz J; Schäkel K; Troost EGC; Krause M; Folprecht G; Bornhäuser M; Bachmann MP; Aust D; Baretton G; Schmitz M
Front Immunol; 2019; 10():602. PubMed ID: 30984181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
